Cell Membrane Engineered Polypeptide Nanonets Mimicking Macrophage Aggregates for Enhanced Antibacterial Treatment
Small · 2024
DOI: 10.1002/smll.202401845 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Jiang Xiao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210009, China. Hauptthemen laut MEDLINE: Macrophages, Anti-Bacterial Agents, Peptides, Cell Membrane. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National High-tech R&D Program, National Key Research & Development Program of China.
Abstract (Originalsprache)
Drug‐resistant bacterial infections and their lipopolysaccharide‐related inflammatory complications continue to pose significant challenges in traditional treatments. Inspired by the rapid initiation of resident macrophages to form aggregates for efficient antibacterial action, this study proposes a multifunctional and enhanced antibacterial strategy through the construction of novel biomimetic cell membrane polypeptide nanonets (R‐DPB‐TA‐Ce). The design involves the fusion of end‐terminal lipidated polypeptides containing side‐chain cationic boronic acid groups (DNPLBA) with cell membrane intercalation engineering (R‐DPB), followed by coordination with the tannic acid‐cerium complex (TA‐Ce) to assemble into a biomimetic nanonet through boronic acid‐polyphenol‐metal ion interactions. In addition to the ability of RAW 264.7 macrophages cell membrane components' (R) ability to neutralize lipopolysaccharide (LPS), R‐DPB‐TA‐Ce demonstrated enhanced capture of bacteria and its LPS, leveraging nanoconfinement‐enhanced multiple interactions based on the boronic acid–polyphenol nanonets skeleton combined with polysaccharide. Utilizing these advantages, indocyanine green (ICG) is further employed as a model drug for delivery, showcasing the exceptional treatment effect of R‐DPB‐TA‐Ce as a new biomimetic assembled drug delivery system in antibacterial, anti‐inflammatory, and wound healing promotion. Thus, this strategy of mimicking macrophage aggregates is anticipated to be further applicable to various types of cell membrane engineering for enhanced antibacterial treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210009, China.
- Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, China.
ORCID-Profile: Xuemei Wang
Förderung
- National Natural Science Foundation of China
- National High-tech R&D Program
- National Key Research & Development Program of China
Zitieren
APA
Xiao, J., Song, Z., Liu, T., Guo, Z., Liu, X., Jiang, H., & Wang, X. (2024). Cell Membrane Engineered Polypeptide Nanonets Mimicking Macrophage Aggregates for Enhanced Antibacterial Treatment. Small. https://doi.org/10.1002/smll.202401845
Vancouver
Xiao J, Song Z, Liu T, Guo Z, Liu X, Jiang H, et al. Cell Membrane Engineered Polypeptide Nanonets Mimicking Macrophage Aggregates for Enhanced Antibacterial Treatment. Small. 2024. doi:10.1002/smll.202401845
BibTeX
@article{Xiao2024,
author = {Xiao, Jiang and Song, Zhongquan and Liu, Tengfei and Guo, Zengchao and Liu, Xiaohui and Jiang, Hui and Wang, Xuemei},
title = {Cell Membrane Engineered Polypeptide Nanonets Mimicking Macrophage Aggregates for Enhanced Antibacterial Treatment},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202401845}
}
EUVIMED